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Behavioral changes in response to stressful stimuli can be con-
trolled via adaptive epigenetic changes in neuronal gene expres-
sion. Here we indicate a role for the transcriptional corepressor
Lysine-Specific Demethylase 1 (LSD1) and its dominant-negative
splicing isoform neuroLSD1, in the modulation of emotional be-
havior. In mouse hippocampus, we show that LSD1 and neuroLSD1
can interact with transcription factor serum response factor (SRF)
and set the chromatin state of SRF-targeted genes early growth
response 1 (egr1) and c-fos. Deletion or reduction of neuroLSD1 in
mutant mice translates into decreased levels of activating histone
marks at egr1 and c-fos promoters, dampening their psychosocial
stress-induced transcription and resulting in low anxiety-like behav-
ior. Administration of suberoylanilide hydroxamine to neuroLSD1KO
mice reactivates egr1 and c-fos transcription and restores the be-
havioral phenotype. These findings indicate that LSD1 is a molecular
transducer of stressful stimuli as well as a stress-response modifier.
Indeed, LSD1 expression itself is increased acutely at both the
transcriptional and splicing levels by psychosocial stress, suggest-
ing that LSD1 is involved in the adaptive response to stress.
epigenetics | stress | immediate early genes | LSD1 | SRF
Dynamic changes in neuronal chromatin through histoneposttranslational modifications affect complex functions such as
learning, memory, and emotional behavior (1). Seminal studies have
shown that mice experiencing different forms of stress, including
psychosocial stress, promote stress-related plasticity through epige-
netic changes at specific genes, including brain-derived neurotrophic
factor (BDNF) and immediate early genes (IEGs) (2–4). These
modifications induce contrasting structural and functional changes in
the hippocampus and the amygdala (5), brain areas responsible for
the expression of anxiety-like behavior (5–8). A decrease in neural
activity in the hippocampus caused by the loss of dendritic arbors
and spines is associated with posttraumatic stress disorder and re-
current depressive illness (5). Therefore, an important challenge for
molecular psychiatry is a better understanding of the epigenetic
regulation of plasticity gene transcription in response to stress (9).
Lysine-Specific Demethylase 1 (LSD1) also known as lysine de-
methylase 1A (KDM1A) is an epigenetic transcriptional corepressor,
tightly associated to Corepressor of REST (CoREST) and histone
deacetylase 2 (HDAC2). It removes methyl groups from mono- and
di-methylated lysine 4 of histone H3 (H3K4), erasing a histone mark
of active transcription (10). In mammals, neurospecific splicing of
microexon E8a generates the dominant-negative splicing isoform of
LSD1 (neuroLSD1), which is required for the acquisition of proper
neurite morphology inherent in neuronal maturation (11). Although
conventional LSD1 acts as a constitutive repressor through its H3K4
demethylase activity, neuroLSD1 is unable to repress transcription
(11, 12). It has been shown recently that neuroLSD1 lacks dimeth-
ylated H3K4 (H3K4me2) demethylase activity, confirming its role
as a dominant-negative LSD1 isoform (13). The neuroLSD1-con-
taining complex also can act as transcriptional activator by ac-
quiring H3K9me2 and H4K20 demethylase activity (13, 14). In
this context, the finding that LSD1 and neuroLSD1 share a subset
of target genes (12–14) suggests that modulation of exon E8a
splicing may represent a mechanism for fine-tuning the transcrip-
tion of selected targets. The generation of a mouse model lacking
microexon E8a (neuroLSD1KO mice) allowed us to characterize
neuroLSD1 as an in vivo modulator of hippocampal excitability.
We reported that shifts in the LSD1/neuroLSD1 ratio in response
to activity contribute dynamically to the control of neuronal ex-
citability by participating in the transcriptional mechanism of ho-
meostatic adaptation (15). In this work we implicate LSD1 and
neuroLSD1 in shaping emotional behavior as fine tuners of psy-
chosocial stress-evoked transcription of IEGs. We found that the
complete lack (neuroLSD1KO) or reduction (neuroLSD1 hetero-
zygosity, hereafter neuroLSD1HET) of neuroLSD1 in the mouse
brain causes low anxiety-like behavior. At the molecular level,
knocking out neuroLSD1 results in H3K4 hypomethylation and H3
hypoacetylation of early growth response 1 (egr1) and c-fos pro-
moters, decreasing their stress-induced transcription. This impair-
ment hinders the acquisition of stress-related plasticity relevant to
anxiety behavior. Moreover, in wild-type animals, LSD1 tran-
scription and alternative splicing are directly modulated by psy-
chosocial stress, indicating that LSD1 and neuroLSD1 not only
participate in the transduction of stressful stimuli but also rep-
resent stress-response modifiers.
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Results
NeuroLSD1-Mutant Mice Display a Low-Anxiety Phenotype. To test
the effect of neuroLSD1 ablation on anxiety-like behavior, we
tested neuroLSD1KO and heterozygous mice (Fig. S1) (15) using
three classic approach–avoidance anxiety paradigms (Fig. 1). In
the elevated plus maze (EPM), we observed that neuroLSD1KO
mice spent more time in and made more entries into the open arms
than their wild-type littermates (Fig. 1A). A trend for increased time
and number of entries in the open arms also was observed in
neuroLSD1HET mice. The total number of entries into each arm of
the maze was comparable in all genotypes, and no differences in
motor function were observed (Fig. S2). In the marble-burying test
(MBT), post hoc analysis indicated a significant decrease in the
number of buried marbles in both neuroLSD1KO and heterozygous
mice compared with wild-type littermates (Fig. 1B). Both geno-
types showed a trend to increased latency to the first burial
(Fig. 1B). In the novelty-suppressed feeding (NSF) test, both
neuroLSD1KO and neuroLSD1HET mice exhibited significantly
decreased latency to feed in the center of the arena compared with
wild-type littermates. No difference was found in the food intake
among genotypes (Fig. 1C). Taken together, the results of be-
havioral tests consistently show that complete lack (neuroLSD1KO
mice) or reduction (neuroLSD1HET mice) of neuroLSD1 expres-
sion affects emotional behavior, resulting in a low-anxiety phenotype.
LSD1 and NeuroLSD1 Are Modulated by Stress and Regulate Stress-
Evoked Transcription of IEGs. To shed light on the molecular
mechanism whereby reduction of neuroLSD1 gives rise to the
low anxiety-like phenotype, we investigated the role of LSD1 in
transducing stressful stimuli into a transcriptional response in the
hippocampus. We tested whether stress could modify LSD1 ex-
pression and the LSD1/neuroLSD1 splicing ratio in the hippo-
campus. To address this point, we took advantage of social
defeat stress (SDS) paradigm (16), a psychosocial stress protocol
that has been well validated with regard to face validity, ability to
challenge the anxiety-like phenotype, and proven usefulness in
unraveling cellular/molecular mechanisms of affective behaviors.
We applied a single session of SDS and measured LSD1 ex-
pression and alternative splicing. In the hippocampus of wild-
type stressed mice we found an increase of about 30% in total
LSD1 protein levels (Fig. 2A) and a twofold increase in total
Fig. 1. NeuroLSD1-mutant mice feature a low anxiety-like phenotype.
Anxiety-like behavior is evaluated by comparing neuroLSD1KO and neuroLSD1HET
mice with wild-type littermates. The anxiety trend is shown on the y axis.
(A) Time spent in the open arm time (F2,27 = 4.65, P = 0.018), entries into the
open arm (F2,27 = 6.16, P = 0.0063), and total entries (which did not show any
difference among genotypes) evaluated in the EPM. (B) Number of marbles
buried (F2,27 = 10.06, P = 0.0002) and latency to the first burial (F2,27 = 2.21, P =
0.12) evaluated in theMBT. (C) Latency to feeding (F2,27 = 9.95, P = 0.0003) and
total amount of food intake evaluated during the NSF test (n = 8–10 mice
per genotype). Data are presented as mean ± SEM; *P < 0.05, **P < 0.01,
***P < 0.001, one-way ANOVA, Tukey post hoc test.
Fig. 2. Hippocampal LSD1 and neuroLSD1 levels
are modified in response to psychosocial stress and
modulate stress-induced transcription of IEGs. Mice
underwent a single session of the SDS test. A sche-
matic representation of the experimental procedure is
shown at the top of the figure. (A–C) Total LSD1 pro-
tein byWestern blot (A), LSD1 total mRNA by qPCR (B),
and LSD1/neuroLSD1 relative percentage by rqfRT-PCR
(C) in the hippocampi of C57BL/6N wild-type mice.
A schematic representation of the four LSD1 splicing
isoforms is shown on the right (n = 5 mice per group).
*P < 0.05, **P < 0.01, ***P < 0.001, Student t test.
(D–G) SDS-induced transcription and protein expres-
sion of egr1 and c-fos in in the hippocampi of wild-
type and neuroLSD1HET mice challenged with SDS.
(D and E) mRNA analysis of egr1 (treatment: F1,44 =
3.561, P = 0.0657; genotype: F1,44 = 6.190, P = 0.0167;
treatment ×genotype: F1,44 = 1.339, P = 0.2535) (D) and
c-fos (treatment: F1,44 = 8.865, P = 0.0047; genotype:
F1,44 = 4.586, P = 0.0378; treatment × genotype:
F1,44 = 2.237, P = 0.1419) (E) (n = 10–14 mice per
condition). (F and G) Western blot protein analysis of
Egr1 (treatment: F1,13 = 6.542, P = 0.0238; genotype:
F1,13 = 6.612, P = 0.0232; treatment × genotype: F1,13 =
26,18, P = 0.0002) (F) and C-Fos (treatment: F1,13 =
8.900, P = 0.0175; genotype: F1,13 = 8.900, P = 0.0175;
treatment × genotype: F1,13 = 23.69, P = 0.0012)
(G) (n = 3 or 4 mice per condition). Results are shown
as mean ± SEM; *P < 0.05, **P < 0.01, ***P < 0.001,
two-way ANOVA, Bonferroni post hoc test.
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LSD1 mRNA (Fig. 2B). Moreover, analysis of LSD1 splicing by
relative quantity fluorescent PCR (rqf-PCR) showed that the
inclusion of LSD1 exon E8a was reduced in stressed mice,
resulting in the down-regulation of the neuroLSD1 isoform and a
relative increase in LSD1 (Fig. 2C). These data indicate that in
the mouse hippocampus stress induces an acute increase in
LSD1 transcription as well as a change in its splicing pattern. To
investigate the role of LSD1 and neuroLSD1 in the molecular
pathway of stress transduction that is functionally relevant to the
shaping of anxiety-like behavior, we further analyzed psychosocial
stress-dependent IEG transcription by comparing the transactiva-
tion of egr-1 and c-fos in neuroLSD1HET mice and wild-type litter-
mates. The expression of these two plasticity genes is known to
mediate the translation of specific stimuli to generate inherent
neuronal plasticity (4). Upon SDS, we found that Egr1 and C-Fos
mRNA were transactivated and protein levels increased only in wild-
type hippocampi; in neuroLSD1HET animals these IEGs did not
respond to stress (Fig. 2 D–G). These data indicate that a proper
amount of neuroLSD1 is necessary to induce IEG transcription ef-
ficiently in response to psychosocial stress and thus suggest that
LSD1 and neuroLSD1 have a role as stress-response transducers.
LSD1 Is a Serum Response Factor Corepressor of IEGs. Transcription
of egr1 and c-fos has been reported to be induced by SDS in
mouse hippocampus (17) and to be related to the behavioral
outcome of SDS in terms of stress susceptibility (4). Serum re-
sponse factor (SRF), together with CREB, is an important
transactivator of egr1, c-fos, and other IEGs (18, 19). We tested
both SRF and cAMP response element-binding protein (CREB)
for their ability to interact with LSD1. Using anti-SRF antibody,
we coimmunoprecipitated LSD1 and the molecular partners
HDAC2 and CoREST from mouse hippocampus protein ex-
tracts under resting conditions (Fig. 3A). Vice versa, using anti-
panLSD1 antibody, we coimmunoprecipitated SRF (Fig. 3B).
Analysis of the anti-SRF immunoprecipitates from HeLa cells
stably expressing HA-LSD1 or HA-neuroLSD1 showed that both
isoforms associate with endogenous SRF protein (Fig. 3C).
Under the same conditions, we could not demonstrate molecular
interaction between LSD1 and CREB (Fig. S4), suggesting that
LSD1 modulation of IEGs could be mediated by SRF. Then we
analyzed LSD1, HDAC2, and SRF chromatin occupancy at the egr1
and c-fos promoters in wild-type and neuroLSD1KO mice. Both
promoters are known to contain serum-responsive elements
(SREs) (20). In particular, five SREs cluster within the egr1 pro-
moter region, whereas a single SRE maps at the c-fos promoter. As
shown in Fig. 3 D and E, quantitative ChIP (qChIP) revealed
significant enrichment of LSD1 and HDAC2 together with SRF at
egr1 and c-fos proximal promoter regions compared with pre-
immune IgG in both wild-type and KO mouse hippocampi. We
did not observe differences between wild-type and neuroLSD1KO
mice in terms of SRF and LSD1 occupancy at each promoter, but
we measured a significant increase in HDAC2 enrichment at the
level of egr1 in neuroLSD1KO mice. SRF is constitutively bound
to its targets (21). Consistently, we did not observe psychosocial
stress-induced modification of the association of SRF with the
egr1 and c-fos promoters (Fig. S5).
To determine the role of SRF in LSD1/neuroLSD1 modula-
tion of activity-dependent IEG transcription (Fig. 2 D and E), we
investigated whether SRF binding to its target sequences was
required for LSD1 and neuroLSD1 to regulate IEG transcrip-
tion. To this aim, we analyzed the effect of reduced levels of
neuroLSD1 on BDNF-induced transactivation of a wild-type egr1
reporter gene (22, 23) or a mutated version lacking the five
SRE, using previously described pGL3-egr1(−370) and pGL3-
egr1(−370m), respectively (20). The two reporter plasmids were
transfected into hippocampal neurons derived from either wild-type
or neuroLSD1HET mice. The egr1 reporter gene was activated by
BDNF when transfected in wild-type neurons, but transactivation
was less efficient in heterozygous neurons. Remarkably, a clear
modulatory effect played by the LSD1/neuroLSD1 ratio on reporter
transactivation can be evidenced only when SRF binds to SRE.
Indeed, BDNF-mediated transactivation did not occur in either of
the two cellular contexts when the egr1 reporter gene carried the
SRE mutation pGL3-egr1(−370m) (Fig. 3G). Importantly,
BDNF-mediated transactivation of the wild-type egr1 reporter
gene was recovered in neurons derived from heterozygous
mice when HA-neuroLSD1 was exogenously overexpressed
(Fig. 3H). These data support the importance of the correct
amount of neuroLSD1, in association with SRF, in eliciting
Fig. 3. LSD1, CoREST, and HDAC2 are previously unidentified SRF core-
pressors. (A and B) Hippocampus protein extracts immunoprecipitated with
anti-SRF antibody (A) or with anti-LSD1 (B) were separated by SDS/PAGE and
detected with the indicated antibodies. In addition to the 67-KDa band in A
and B, the SRF antibody detected a 57-KDa band described as a neurospecific
splicing isoform (28) (also see Fig. S3). (C) HeLa cells overexpressing HA-LSD1
or HA-neuroLSD1 immunoprecipitated with anti-SRF antibody were sepa-
rated by SDS/PAGE and were immunodecorated with anti-HA. (D–F) qChIP
experiments performed on hippocampal chromatin using anti-SRF, anti-
panLSD1, and anti-HDAC2 antibodies together with IgG as mock treatment
(dashed lines represent the highest mock treatment of the two genotypes)
on egr1 (D) and c-fos (E) promoters and an unrelated control (the egr1 distal
genomic region) (F). Data are shown as mean ± SEM; *P = 0.035, Student t
test. (G and H) In neurons, LSD1/neuroLSD1 regulation of IEGs’ activity-
dependent transcription requires SRF binding to DNA. (G) Reporter assay in
primary wild-type and neuroLSD1HET hippocampal neurons transfected with
the pGL3-egr1(−370) construct (treatment: F1,28 = 34.74, P < 0.0001; geno-
type: F1,28 = 2.459, P = 0.1281; treatment × genotype: F1,28 = 5.384, P =
0.0278) and the mutated version lacking the five SREs, pGL3-egr1(−370m)
(treatment × genotype: F1,20 = 0.2209, P = 0.6435). (H) Reporter assay in
primary wild-type and neuroLSD1HET hippocampal neurons transfected with
the pGL3-egr1(−370) construct and the pCGN-HA vector (treatment: F1,11 =
207.2, P < 0.0001; genotype: F1,11 = 5.319, P = 0.0416; treatment × genotype:
F1,11 = 7.116, P = 0.0219) or pCGN-HA-neuroLSD1 (treatment × genotype:
F1,11 = 0.6388, P = 0.4411). Reporter activity was assayed in basal conditions
and after treatment with BDNF. (n = 3–8 per condition). Results are shown as
mean ± SEM; *P < 0.01, two-way ANOVA, Bonferroni post hoc test.
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IEG transactivation in response to stimuli instrumental to the
acquisition of inherent forms of neuroplasticity.
NeuroLSD1-Mutant Mice Display Altered IEG Chromatin Structure.
SRF is comparably associated with IEG promoters in wild-type
and neuroLSD1KO mice (Fig. 3 D and E). This finding suggests
that, rather than being caused by differential SRF association
with DNA, the impaired psychosocial stress-induced IEG tran-
scription observed in neuroLSD1-mutant mice could result from
altered chromatin structure at IEG promoters. We analyzed
chromatin structure in wild-type and neuroLSD1-mutant mice by
assessing their level of H3K4 methylation and H3 acetylation
(H3K9/K14ac), histone marks erased by LSD1 and HDAC2. We
applied qChIP to whole mouse hippocampus and found that in
both neuroLSD1KO and neuroLSD1HET mice H3K4me2 and
H3K9/K14ac were decreased at the egr1 and c-fos proximal
promoter regions, including SRE, compared with wild-type lit-
termates (Fig. 4 A and B). No differences were observed among
genotypes at an unrelated control region devoid of SRE (Fig. 4C).
This specific chromatin compaction primed by LSD1-induced
H3K4 hypomethylation, but also based on H3 hypoacetylation,
produces minor modifications of IEGs’ basal transcription (CTRL
in Fig. 2 D and E) but may account for the defective trans-
activation of egr1 and c-fos measured in neuroLSD1HET mice in
response to psychosocial stress (SDS in Fig. 2 D and E).
The Low Anxiety-Like Phenotype of NeuroLSD1-Mutant Mice Is
Related to Decreased Neuroplasticity. NeuroLSD1 genetic abla-
tion affects the psychosocial stress-dependent transcription of
egr1 and c-fos through direct LSD1-mediated chromatin com-
paction, suggesting reduced neuroplasticity. We reasoned that if
the low-anxiety behavior of neuroLSD1-mutant mice is related
to this peculiar molecular phenotype, reactivation of IEG tran-
scription to reinstate neuroplasticity by systemic HDAC inhibition
(24, 25) should restore normal anxiety. We systemically treated
mice with a clinically approved HDAC inhibitor (HDACi), sub-
eroylanilide hydroxamic acid (SAHA), 25 mg/kg i.p. for 10 d Fig.
S6), to overcome IEGs’ repressive chromatin structure observed in
Fig. 4. NeuroLSD1KO and neuroLSD1HET hippocampi display reduced levels
of H3K4 dimethylation and H3K9/K14 acetylation at the egr1 and c-fos
promoters. Hippocampal chromatin from neuroLSD1KO or neuroLSD1HET
mice or wild-type littermates was immunoprecipitated with anti-H3K4me2
and anti-H3K9/K14ac antibodies. Enrichments are shown as percentage of
input. Shown is qPCR analysis at the level of egr1 (anti-H3K4me2: F2,23 =
14.07, P = 0.0001; anti-H3K9/14ac: F2,15 = 1.667, P = 0.2220) (A) or c-fos (anti-
H3K4me2: F2,28 = 19.74, P < 0.0001; anti-H3K9/14ac: F2,22 = 4.379, P = 0.0251)
(B) proximal promoters and the unrelated control (egr1 distal genomic re-
gion) (C) (n = 5–13 per condition). Data are shown as mean ± SEM; *P < 0.05;
**P < 0.01; ***P < 0.001, one-way ANOVA, Tukey post hoc test; §P = 0.0269,
Bartlett’s test.
Fig. 5. Treatment with SAHA normalizes the anxiety-like phenotype of neuroLSD1 mutants. (A–C) Anxiety-like behavior in neuroLSD1KO mice compared with wild-
typemice treatedwith SAHA or vehicle (VEH). The anxiety trend is shown. (A) Entries into the open arm (treatment: F2,54= 1.847, P = 0.1676; genotype: F1,54 = 19.70, P=
0.001; treatment ×genotype: F2,54 = 3.643, P = 0.032) and time spent in the open arm (treatment: F2,54 = 5.43, P = 0.007; genotype: F1,54 = 6.979, P = 0.0108; treatment ×
genotype: F2,54 = 6.969, P = 0.002) evaluated in the EPM. (B) The number of buried marbles (treatment: F2,54 = 4.436, P = 0.0165; genotype: F1,54 = 22.35, P < 0.0001;
treatment × genotype: F2,54 = 4.566, P = 0.0147), latency to first burial (treatment: F2,54 = 5.45, P = 0.006; genotype: F1,54 = 2.285, P = 0.1365; treatment × genotype:
F2,54 = 7.834, P = 0.001) evaluated in the MBT. (C) Latency to the first bite (treatment: F2,54 = 0.08, P = 0.92; genotype: F1,54 = 10.29, P = 0.0023; treatment × genotype:
F2,54 = 6.26, P = 0.004) evaluated in the NSF. (n = 8–10 mice per genotype for each condition). (D–F) Hippocampal chromatin from neuroLSD1
KO or wild-type mice
treated with SAHA or vehicle and immunoprecipitated by anti-H3K4me2 and anti-H3K9/K14ac antibodies. Enrichment at specific loci is shown as percentage of
input. (D) egr1 promoter (anti-H3K4me2, treatment: F1,16 = 2.141, P = 0.1628; genotype: F1,16 = 1.4405, P = 0.2468; treatment × genotype: F1,16 = 9.080, P = 0.0082)
(anti-H3K9/K14, treatment: F1,14 = 0.0429, P = 0.8388; genotype: F1,14 = 2.376, P = 0.1455; treatment × genotype: F1,14 = 2.723, P = 0.1212; genotype). (E) c-fos
promoter (anti-H3K4me2, treatment: F1,16 = 11.57, P < 0.0036; genotype: F1,16 = 3.018, P = 0.1015; treatment × genotype: F1,16 = 2.938, P = 0.1058) (anti-H3K9/K14,
treatment F1,13 = 3.438, P < 0.0865; genotype: F1,13 = 0,2726, P = 0.6104; treatment × genotype: F1,13 = 0.3492, P = 0.5647). (F) Unrelated control (egr1 distal
genomic region) (n = 3–6 per condition). Datasets referred to as “VEH” in D–F are different from those in Fig. 4 in which naive mice were used. Data are shown as
mean ± SEM; *P < 0.05, **P < 0.01, ***P < 0.001, two way ANOVA, Bonferroni post hoc test; §P < 0.05, Student t test.
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neuroLSD1 mutants. We chose SAHA, which is able to cross the
blood–brain barrier (24), for its established ability to increase
hippocampal plasticity by promoting the transcription of plas-
ticity-related genes, including egr1 and c-fos (24, 26). We found
that in resting conditions SAHA treatment induced sustained
levels of egr1 and c-fos transcription in both wild-type and neu-
roLSD1HET mice (SAHA-treated CTRL in Fig. S7). These levels
were comparable to (or higher than) those observed in wild-type
mice exposed to psychosocial stress (SDS in Fig. S7), and c-fos
levels were further increased by SDS (SAHA-treated SDS in Fig.
S7). Importantly, SAHA treatment did not affect the association
of SRF with its chromatin targets (Fig. S8). To analyze the effect
of SAHA treatment on the anxiety-like behavior of neuro-
LSD1KO and wild-type mice, we used the paradigms described
earlier. Remarkably, SAHA significantly increased anxiety-like
behavior in neuroLSD1KO mice as evidenced by decreased time
spent in the open arms and the decreased number of entries into
the open arm as compared with vehicle-treated neuroLSD1KO
mice evaluated in the EPM (Fig. 5A). Post hoc analysis revealed
that in neuroLSD1KO mice SAHA restored anxiety-like behavior
to wild-type levels. Similarly in the MBT the two parameters—
reduced number of marbles buried and increased latency to first
burial proper of neuroLSD1KO mice—were restored to wild-type
levels by SAHA but not by vehicle treatment (Fig. 5B). In the NSF
test, SAHA increased the latency to feeding of neuroLSD1KO
mice compared with vehicle-treated neuroLSD1KO mice (Fig. 5C).
It is important to note that SAHA treatment did not exert a
measurable effect on the behavior of wild-type animals, although
it induced up-regulation of basal IEG transcription (Fig. S7).
In neuroLSD1-mutant mice, poor IEG transcription in response
to stimuli results from the LSD1/HDAC2-mediated decrease in
positive histone marks at IEG proximal promoters (Fig. 4 A and
B). Interestingly, SAHA-treated neuroLSD1KO mice exhibited a
significant increment in H3K9/K14ac and H3K4me2 compared
with vehicle-treated mice at both the egr1 and c-fos promoters
(Fig. 5 D and E). The observation that the same loci were not
affected by SAHA in wild-type mice suggests that the increased
transcription of IEGs should be ascribed, at least in part, either
to modifications of different histone marks at regulatory regions
targeted by SRF/LSD1/HDAC2 or to changes at genomic regions
not targeted by SRF, as would be expected, given the broad effect
of SAHA on the overall acetylation of both histone H3 and H4
(24). We cannot exclude the possibility that SAHA-mediated
increase of neuroplasticity in other anxiety-related brain
structures could contribute to the normalization of anxiety in
neuroLSD1 mutants.
Discussion
In this work we shed light on the molecular mechanisms un-
derlying gene–environment interactions in the mouse brain. We
propose that epigenetic enzyme LSD1 and its dominant negative
isoform neuroLSD1 serve as transcriptional modulators shaping
the chromatin-encoded memory of stressful experiences. In
particular, we suggest that the splicing-regulated dual system
LSD1/neuroLSD1 can act as a fine transduction tuner of psy-
chosocial stress by mediating transcriptional modulation of
plasticity genes. We discovered that neuroLSD1 mutants’ low-
anxiety behavior is related to a defective stress response, i.e.,
deficient psychosocial stress-induced transactivation of egr1 and
c-fos. Stress is known to affect the plasticity and excitability of the
hippocampus (27). Together with the amygdala and prefrontal
cortex, the hippocampus is part of the complex circuitry involved
in mammalian trait anxiety, and its substantial role has been
acknowledged (5, 7, 8, 28). We show that in the hippocampus,
LSD1/neuroLSD1 repression of plasticity genes can be exerted
in association with the transcription factor SRF. However, we
cannot exclude the possibility that transcription factors other
than SRF could contribute to recruiting LSD1/CoREST/HDAC2
to the IEG promoters. The association of LSD1 and neuroLSD1
with SRF is consistent with its ability to regulate the same targets
either as a transcriptional activator in response to stimuli or as a
repressor in basal conditions (19). SRF’s repressive function has
been described extensively (29); this work contributes to our
understanding by characterizing the molecular basis of SRF’s
repressive activity. Interestingly, SRF is known to be constitu-
tively bound to the DNA of its target genes both in resting
conditions and upon stimulation (21), and its association with
IEG promoters is not affected by psychosocial stress. Thus, the
difference in the proneness of egr1 and c-fos to transcription
observed in wild-type versus neuroLSD1-mutant mice depends
mainly on differences in the LSD1/neuroLSD1 ratio, resulting in
changes in the H3K4me2 levels, in the two genotypes. When the
dominant-negative neuroLSD1 isoform, lacking H3K4 demeth-
ylase activity, is low (neuroLSD1HET) or absent (neuroLSD1KO),
the LSD1 isoform is increased or is the only one expressed. Its
repressive function toward egr1 and c-fos transcription is in-
creased aberrantly, establishing a repressive chromatin state that
limits the extent to which transactivation of these genes can
occur in response to psychosocial stress (Fig. 6). Elevated LSD1
levels not only cause H3K4 hypomethylation but also facilitate
HDAC deacetylase activity, as indicated by decreased H3K9/
K14ac levels observed at the same promoters. In vitro, in-
terdependence of LSD1 and HDAC activities has been described
extensively (30), and our findings further demonstrate this
functional interplay in the brain.
A central finding of this study is the discovery that in wild-type
animals, in physiological conditions, LSD1 is increased and
neuroLSD1 is decreased in response to stress. In heterozygous
mice, the genetically produced reduction of neuroLSD1 is able
per se to impact IEG transactivation negatively in response to
stress. Thus, stress-induced neuroLSD1 down-regulation should be
sufficient to buffer the stress-driven transcription of plasticity
genes in a wild-type animal. This modulation could represent a
possible homeostatic mechanism able to mitigate intense or
prolonged stress-induced molecular responses and thereby
maintain acquired plasticity at an adaptive level, although im-
mediately after the SDS we did not observe a readout on chro-
matin (Fig. S9). Chronic stress results in long-lasting chromatin
modifications that increase the repression of plasticity-related
Fig. 6. Graphical model of SRF-LSD1/neuroLSD1–mediated transcriptional
modulation of the IEGs. Given the dimeric nature of the corepressor com-
plex, it is conceivable that, depending on the relative amounts of LSD1 and
neuroLSD1, both LSD1/LSD1 homodimers and LSD1/neuroLSD1 heterodimers
could be present in vivo (11). (A) In wild-type mice, in resting conditions, IEG
transcription is repressed but permits activity-induced transcription. (B) Upon
stressful stimuli, IEG transcription is fully activated. (C and D) In neuroLSD1-
mutant mice, in resting conditions (C), a more condensed chromatin struc-
ture at the IEG proximal promoters does not permit stress-induced tran-
scription (D). (E and F) Chronic treatment with the HDAC inhibitor SAHA
leads to normalization of anxiety in neuroLSD1 mice.
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genes (2–4). In particular, egr1 has been reported to be down-
regulated in mice stressed by chronic social defeat and in post-
mortem brains of depressed human subjects, suggesting a path-
ogenic role for this down-regulation (4, 31). In this regard, it is
conceivable that repeated LSD1 up- and neuroLSD1 down-
regulation in response to chronic stress could induce H3K4
hypomethylation at the egr1 promoter (Fig. S10). We have shown
previously that dendrite shrinkage can be produced in cultured
neurons by knocking down neuroLSD1 (11). The decrease of
neuroLSD1 in the hippocampus that we observed in response to
stress might represent an epigenetic mechanism instrumental in
the shrinkage of dendritic arbors and loss of dendritic spines
seen in stress-related psychiatric disorders (32).
SAHA treatment successfully restored IEG transcription
and at the same time led to a phenotypical normalization of
neuroLSD1 mutants’ emotional behavior, suggesting that the low
anxiety-like phenotype is related to reduced neuroplasticity. As
expected, we also observed an SAHA-mediated increase in
H3K9/K14ac and H3K4me2, histone marks specifically affected
in neuroLSD1 mutants. However, because of the broad SAHA-
induced chromatin remodeling (24), other effects on histone and
nonhistone proteins are likely also. All our results are consistent
with the idea that pharmacological targeting of LSD1 demethylase
activity through specific inhibitors or by direct neurospecific splicing
modulation, in combination with or as an alternative to HDACi,
could represent a strategy for treating mood and anxiety disorders,
including depression (33, 34). HDACi have been proposed to
exert antidepressant and anxiolytic effects (34). Therefore, the
SAHA-mediated restoration of anxiety in neuroLSD1-mutant
mice to wild-type levels highlights an apparently counterintui-
tive effect of SAHA on emotional behavior. However, similar
bidirectional effects of HDACi have been described in regard to
memory. Indeed, SAHA and other HDACi are able to improve
memory by increasing synaptic plasticity in the hippocampus
(24), but they also can attenuate remote fear memories by the
same molecular mechanism (25). In both these contexts, it has
been suggested that HDACi act by reactivating plasticity-related
genes, priming the hippocampal transcriptome to reinstate neu-
roplasticity (25). In conclusion we suggest that specific amounts of
neuroLSD1 are necessary to couple stress exposure with its mo-
lecular response, i.e., in the expression of plasticity genes. It is
tempting to speculate that neuroLSD1 could enhance mammals’
ability to survive in a complex and ever-changing environment by
finely tuning the molecular machinery that memorizes harmful
events through stress-related plasticity.
Methods
All procedures involving animals were carried out in accordance with the
European regulations (2010/63/UE) and Italian Council on Animal Care
Guidelines (Legislative Decree no. 26, 2014) and were approved by the
Italian Ministry of Health (no. 234/2012B and 275/2015) and by University of
Milan IRB no. 27/2014. See SI Methods for further details of SDS procedures
(16), the anxiety test (35–37), gene-expression analysis through quantitative
PCR (qPCR) and rqf-PCR (11), ChIP protocols (15), primers, and antibodies.
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